Tower Research Capital (TRC)’s Acutus Medical Inc AFIB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-11,869
| Closed | -$2.23K | – | 6145 |
|
|
2024
Q1 | $2.23K | Buy |
11,869
+105
| +0.9% | +$21 | ﹤0.01% | 5092 |
|
|
2023
Q4 | $2.38K | Sell |
11,764
-2,353
| -17% | -$922 | ﹤0.01% | 5226 |
|
|
2023
Q3 | $9.84K | Buy |
14,117
+1,205
| +9% | +$781 | ﹤0.01% | 4176 |
|
|
2023
Q2 | $11.5K | Buy |
12,912
+5,140
| +66% | +$4.36K | ﹤0.01% | 3971 |
|
|
2023
Q1 | $6K | Buy |
7,772
+7,694
| +9,864% | +$10K | ﹤0.01% | 4910 |
|
|
2022
Q4 | $0 | Sell |
78
-127
| -62% | -$105 | ﹤0.01% | 6559 |
|
|
2022
Q3 | $0 | Sell |
205
-10,985
| -98% | -$13.3K | ﹤0.01% | 6641 |
|
|
2022
Q2 | $12K | Buy |
11,190
+4,007
| +56% | +$3.44K | ﹤0.01% | 4329 |
|
|
2022
Q1 | $10K | Buy |
7,183
+3,905
| +119% | +$8.35K | ﹤0.01% | 4384 |
|
|
2021
Q4 | $11K | Buy |
3,278
+1,549
| +90% | +$8.72K | ﹤0.01% | 4487 |
|
|
2021
Q3 | $15K | Buy |
1,729
+359
| +26% | +$4.72K | ﹤0.01% | 4009 |
|
|
2021
Q2 | $23K | Sell |
1,370
-2,132
| -61% | -$31.2K | ﹤0.01% | 3776 |
|
|
2021
Q1 | $47K | Buy |
3,502
+3,073
| +716% | +$69.2K | ﹤0.01% | 3185 |
|
|
2020
Q4 | $12K | Sell |
429
-1,291
| -75% | -$34.9K | ﹤0.01% | 4224 |
|
|
2020
Q3 | $51K | Buy |
+1,720
| New | +$52.2K | ﹤0.01% | 3533 |
|
Other funds holding AFIB
Tower Research Capital (TRC)'s AFIB Position: Q2 2024 in Review
Tower Research Capital (TRC) sold out of Acutus Medical Inc (AFIB) in Q2 2024, closing a stake of 11,869 shares — an estimated $2.23K sold.
Tower Research Capital (TRC) first reported a position in AFIB in Q3 2020 and held it in 15 quarters. The position peaked at $51K in Q3 2020. 1 fund tracked by Wall St. Rank holds AFIB as of Q2 2024.
- Tower Research Capital (TRC) reported no remaining Acutus Medical Inc position as of Q2 2024 after selling out during the quarter.
- Tower Research Capital (TRC) sold 11,869 Acutus Medical Inc shares in Q2 2024, an estimated $2.23K.
- Tower Research Capital (TRC) first reported a position in Acutus Medical Inc in Q3 2020 and held it in 15 quarters.
- Tower Research Capital (TRC)'s Acutus Medical Inc position peaked at $51K in Q3 2020.
- 1 fund tracked by Wall St. Rank held Acutus Medical Inc as of Q2 2024.
Based on Tower Research Capital (TRC)'s 13F filing for Q2 2024, filed 13 Aug 2024.